These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 8765347

  • 1. [The dosage-performance effects on Ca-Ski and HPK cells in relation to the dose and fractionation].
    Schulz-Wendtland R, Krämer S, Keilholz L, Pflüger S, Lang N.
    Strahlenther Onkol; 1996 Aug; 172(8):439-45. PubMed ID: 8765347
    [Abstract] [Full Text] [Related]

  • 2. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix.
    Leborgne F, Fowler JF, Leborgne JH, Zubizarreta E, Chappell R.
    Radiat Oncol Investig; 1997 Aug; 5(6):289-99. PubMed ID: 9436246
    [Abstract] [Full Text] [Related]

  • 3. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
    Ferrigno R, Nishimoto IN, Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Salvajoli JV.
    Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):1108-16. PubMed ID: 15990016
    [Abstract] [Full Text] [Related]

  • 4. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
    Falkenberg E, Kim RY, Meleth S, De Los Santos J, Spencer S.
    Brachytherapy; 2006 Jul 15; 5(1):49-55. PubMed ID: 16563997
    [Abstract] [Full Text] [Related]

  • 5. Prospective study of HDR (192Ir) versus MDR (137Cs) intracavitary brachytherapy for carcinoma of the uterine cervix.
    Tanaka E, Oh RJ, Yamada Y, Shiomi H, Nakamura S, Shimamoto S, Teshima T, Inoue T, Inoue T.
    Brachytherapy; 2003 Jul 15; 2(2):85-90. PubMed ID: 15062145
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. High-dose versus low-dose rate brachytherapy in definitive radiotherapy of cervical cancer.
    Kucera H, Pötter R, Knocke TH, Baldass M, Kucera E.
    Wien Klin Wochenschr; 2001 Jan 15; 113(1-2):58-62. PubMed ID: 11233470
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Determination of the appropriate fraction number and size of the HDR brachytherapy for cervical cancer.
    Liu WS, Yen SH, Chang CH, Yang KM, Wu YP, Chen KY.
    Gynecol Oncol; 1996 Feb 15; 60(2):295-300. PubMed ID: 8631555
    [Abstract] [Full Text] [Related]

  • 15. Californium-252 (252Cf) versus conventional gamma radiation in the brachytherapy of advanced cervical carcinoma long-term treatment results of a randomized study.
    Tacev T, Ptácková B, Strnad V.
    Strahlenther Onkol; 2003 Jun 15; 179(6):377-84. PubMed ID: 12789463
    [Abstract] [Full Text] [Related]

  • 16. Overview of radiosensitivity of human tumor cells to low-dose-rate irradiation.
    Williams JR, Zhang Y, Zhou H, Gridley DS, Koch CJ, Slater JM, Little JB.
    Int J Radiat Oncol Biol Phys; 2008 Nov 01; 72(3):909-17. PubMed ID: 19014780
    [Abstract] [Full Text] [Related]

  • 17. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
    Pos FJ, Horenblas S, Lebesque J, Moonen L, Schneider C, Sminia P, Bartelink H.
    Int J Radiat Oncol Biol Phys; 2004 Jul 01; 59(3):696-705. PubMed ID: 15183473
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T, Ito K, Saitoh J, Noda SE, Harashima K, Sakurai H, Nakayama Y, Yamamoto T, Suzuki K, Nakano T, Niibe H.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):463-71. PubMed ID: 16168838
    [Abstract] [Full Text] [Related]

  • 20. Pulsed-dose-rate and low-dose-rate brachytherapy: comparison of sparing effects in cells of a radiosensitive and a radioresistant cell line.
    Pomp J, Woudstra EC, Kampinga HH.
    Radiat Res; 1999 Apr 01; 151(4):449-53. PubMed ID: 10190497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.